Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2005
02/09/2005CN1188426C Antibodise against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
02/09/2005CN1188172C G-CSF conjugates
02/09/2005CN1188167C Method of controlling the qualities of attenuated pox vaccine
02/09/2005CN1188031C Corticotropin releasing factor receptor 2 deficient mice and uses thereof
02/09/2005CN1188027C Cytoplasmic male sterile brassica oleracea plant, and method for obtaining such plant
02/08/2005US6852911 By using two different recombinases to generate different deletions in a transgenic construct in a plant thereby resulting in a male-sterile plant with two different constructs in an allelic relationship to one another
02/08/2005US6852910 Plant recombination proteins
02/08/2005US6852909 Process for producing female-sterile plants
02/08/2005US6852908 Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production
02/08/2005US6852907 Resistance in plants to infection by ssDNA virus using inoviridae virus ssDNA-binding protein, compositions and methods of use
02/08/2005US6852906 Monitoring enzyme activity in cells; obtain cells, incubate with labeled substrate, detect adjustment in physical properties of cell, adjustment in physical property indicates enzyme activity
02/08/2005US6852851 DNA isolation method
02/08/2005US6852848 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders
02/08/2005US6852847 B7 nucleic acid molecules, proteins encoded by such nucleic acid molecules, antibodies raised against such proteins and inhibitors of such proteins or nucleic acid molecules
02/08/2005US6852846 Viral amplification of recombinant messenger RNA in transgenic plants
02/08/2005US6852841 Frozen food product
02/08/2005US6852839 Fhm, a novel member of the TNF ligand supergene family
02/08/2005US6852838 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders
02/08/2005US6852837 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis
02/08/2005US6852836 Gene encoding brain-specific membrane protein
02/08/2005US6852835 DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses
02/08/2005US6852834 Fusion peptides isolatable by phase transition
02/08/2005US6852709 Biodegradable particles for use in time release agents and gene therapy
02/08/2005US6852704 Compositions and methods for reverse gene therapy, wherein a gene therapy vector encoding a gene product (e.g. a protein) which is usually only expressed in cells of an abnormal tissue is delivered to a cell of an animal afflicted with a disease
02/08/2005US6852703 A vector comprising a nucleotide sequence of interest ("NOI") encoding a product of interest ("POI") is described. The NOI and/or the POI is capable of recognizing a tumor, such that in use the vector is capable of delivering the NOI and/or the POI
02/08/2005US6852538 Response element (RE) for Nur family members
02/08/2005US6852537 Transgenic circulating endothelial cells
02/08/2005US6852536 Antisense modulation of CD36L 1 expression
02/08/2005US6852535 A transcribed non-naturally occurring RNA molecule comprising a desired RNA molecule, wherein the 3' region of the RNA is able to base-pair with at least 8 bases at the 5' terminus of the same RNA molecule
02/08/2005US6852530 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
02/08/2005US6852529 Gloucose-regulated mRNA instability element
02/08/2005US6852528 Human and mouse uroplakin II gene transcriptional regulatory elements
02/08/2005US6852523 B.subtilis, wherein one or more genes involved in the biosynthesis of isovaleric acids have been modified such that the strain cannot produce substantial amounts of isovaleric acids; improved food flavors
02/08/2005US6852522 Methods and interferon deficient substrates for the propagation of viruses
02/08/2005US6852521 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
02/08/2005US6852520 DSP-2 dual-specificity phosphatase
02/08/2005US6852519 MAP/extracellular signal-regulated kinases which effect protein phosphorylation; biochips
02/08/2005US6852518 Glycosyl sulfotransferases GST-4α, GST-4β, and GST-6
02/08/2005US6852516 Culturing a coryneform bacterium which has been modified to increase intracellular pyruvate carboxylase activity and L-glutamic acid producing ability in a medium to produce and accumulate L-glutamic acid in culture
02/08/2005US6852515 For heparan sulfate binding extracellular domain; proteoglycans; in-situ; tumors/wound healing
02/08/2005US6852514 Hyaluronate synthase gene and uses thereof
02/08/2005US6852512 Expression vectors for production of foreign proteins as soluble forms
02/08/2005US6852511 Heat-inducible promoter
02/08/2005US6852510 Host cells containing multiple integrating vectors
02/08/2005US6852509 Anti-P53 single-chain antibody fragments and their uses
02/08/2005US6852507 Recombinant baculovirus and use thereof in the production of monoclonal antibodies
02/08/2005US6852498 Screening efficiency of microbiocides at preventing oomycete infections; obtain sample containing oomycetes, incubate with microbiocide, monitor oomycete response to microbiocide
02/08/2005US6852497 Fusion protein
02/08/2005US6852495 Improving process for isolating/purifying nucleotide sequences from viruses, bacteria, fungi, protozoa, plants and animals
02/08/2005US6852492 Apparatus for use in sequencing nucleotide sequences
02/08/2005US6852491 Oligonucleotide primer sets, probes; kits; detecting in test sample Human Immunodeficiency Virus Type 1 (HIV-1)
02/08/2005US6852490 Methods of using an array of pooled probes in genetic analysis
02/08/2005US6852489 Simple and quick method for determining the nucleotide sequence of a mitochondrial 21S ribosomal RNA gene of yeast belonging to Saccharomyces cerevisiae
02/08/2005US6852488 Identifying a base in a nucleic acid
02/08/2005US6852486 Detection of leukocyte antigen in sample; obtain cell sample, incubate with bindng protein, detect bound protein, presence of bound protein indicates leukocyte antigen presence
02/08/2005US6852346 Improving rheological properties and quality of bread, alimentary paste products, noodles; strength and stability
02/08/2005US6852334 Cationic peg-lipids and methods of use
02/08/2005US6852321 Lectin-derived progenitor cell preservation factor and methods of use
02/08/2005US6852319 Generation of antibody with preferential binding activity; obtain plant, transform with nucleotide sequences coding immunoglobulin, express nucleotide sequences, recover imunoglobulin
02/08/2005CA2473458A1 The combination of circulating epstein-barr virus (ebv) dna in the serum or plasma of patients and a method to assess ebv subtypes for the prediction and detection of epstein-barrvirus associated cancers
02/08/2005CA2323726C Control of gene expression
02/08/2005CA2323450C Assay of igfbp complex
02/08/2005CA2315242C Non-bacterial cloning in delivery and expression of nucleic acids
02/08/2005CA2302551C .beta.-fructofuranosidase and its gene
02/08/2005CA2201756C Self-quenching fluorescence probe and method
02/08/2005CA2184183C Inhibin compositions and methods of use thereof
02/08/2005CA2180103C Gene encoding adseverin
02/08/2005CA2150928C Expression system for producing apolipoprotein ai-m
02/08/2005CA2116914C Novel plasmid for production of crm protein and diphtheria toxin
02/08/2005CA2110933C Kainate-binding, human cns receptors of the eaa3 family
02/05/2005CA2473337A1 Polymorphisms of the 5' region of the human 5-ht1a gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses
02/03/2005WO2005010794A2 Method for determining metabolic flux affecting substance production
02/03/2005WO2005010525A1 Vacuum-packed solid support array and process for producing the same
02/03/2005WO2005010212A1 Polynucleotide sequence variants
02/03/2005WO2005010208A1 Improved method of amplifying atp and use thereof
02/03/2005WO2005010204A2 Rapid nucleic acid isolation method and compositions therefore
02/03/2005WO2005010198A2 Protein logic gates
02/03/2005WO2005010197A2 A systemic small rna signaling system in plants
02/03/2005WO2005010191A1 Plant cell cycle genes and methods of use
02/03/2005WO2005010190A1 Ssx-2 peptides presented by hla class ii molucules
02/03/2005WO2005010189A1 OLIGONUCLEOTIDE INHIBITING THE EXPRESSION OF StAR-BINDING PROTEIN (SBP) GENE AND METHOD THEREFOR
02/03/2005WO2005010188A2 Rnas able to modulate chromatin silencing
02/03/2005WO2005010187A1 Methods for generating or increasing revenues from crops
02/03/2005WO2005010185A1 Rna capable of inhibiting expression of klf5 gene
02/03/2005WO2005010184A1 Method of detecting mutation
02/03/2005WO2005010183A1 Method of judging risk for onset of drug-induced granulocytopenia
02/03/2005WO2005010181A1 Method for detecting nucleic acid
02/03/2005WO2005010179A1 Method for constructing and modifying large dna molecules
02/03/2005WO2005010177A1 Non-watson crick base pair-metal complex
02/03/2005WO2005010175A1 Method for producing l-lysine or l-threonine using escherichia bacteria having attnuated malic enzyme activity
02/03/2005WO2005010169A2 High throughput or capillary-based screening for a bioactivity or biomolecule
02/03/2005WO2005010165A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
02/03/2005WO2005010161A2 Device and method to facilitate directed delivery and electroporation
02/03/2005WO2005010156A2 Genes encoding carotenoid compounds
02/03/2005WO2005010155A2 Methods of decoupling reaction scale and protein synthesis yield in batch mode
02/03/2005WO2005010149A2 Subgroup b adenoviral vectors for treating disease
02/03/2005WO2005010146A2 Adenoviral e1a/e1b complementing cell line
02/03/2005WO2005010145A2 Method and compositions for detection and enumeration of genetic variations
02/03/2005WO2005010144A2 Displacing a plasmid in a bacterial population
02/03/2005WO2005010143A2 Methods of treatment and disgnosis using modulators of virus-induced cellular gene sequences